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New Roles for Src Kinases Minireview
in Control of Cell Survival
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membrane by lipid modifications, and is poised to inter-
act with, and to be activated by, a variety of signals that
are initiated at the cell surface.
The autoinhibition of Src by multiple intramolecular
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membrane-linked receptors and docking proteins. For
example, the protein tyrosine kinase activity of Src can
be stimulated by binding of proteins containing a PXXPSrc was initially discovered as the oncogenic protein
motif, a sequence that functions as a binding site for(v-Src) of the retrovirus Rous sarcoma virus. A ubiquitously
the SH3 domain of Src. In addition, the protein tyrosineexpressed and highly conserved cellular homolog of
kinase activity can be activated by phosphotyrosine-v-Src was subsequently discovered. Much of the original
containing proteins that bind to the SH2 domain andresearch on v-Src and its cellular homolog (Src) paved
thus compete with and prevent the autoinhibition con-the way for our current understanding of how oncogenes
ferred by intramolecular binding of the SH2 domain tocause cell transformation. The Src family of nonreceptor
pY527. Src can also be activated by protein tyrosine phos-protein tyrosine kinases, including Src, Lyn, Fyn, Lck,
phatases that specifically dephosphorylate the pY527 au-Hck, Fgr, Blk, and Yes, have important roles in receptor
toinhibitory site. Once Src is in an ªopenº configuration,signaling and cellular communication (reviewed in
the intrinsic protein tyrosine kinase activity is activatedThomas and Brugge, 1997). While most Src kinases are
by intermolecular phosphorylation of a key tyrosine resi-broadly expressed (i.e., Src, Fyn, Yes), certain members
due in the activation loop of the PTK core. This stepof the family such as Hck, Blk, or Lck exhibit a restricted
was shown to be obligatory for the activation of alltissue expression.
known protein tyrosine kinases (Weiss and Schles-It is now well established that Src kinases play an
singer, 1998).important role in cell cycle control, in cell adhesion and
Src kinases are activated by a variety of cell surfacemovement, and in cell proliferation and differentiation
receptors. Many surface receptors contain relativelyin a variety of cells and tissues (Thomas and Brugge,
short cytoplasmic domains and lack intrinsic catalytic1997). These diverse functions are due to the Src kinases
activities. These cytoplasmic domains contain bindingpivotal role as membrane-attached molecular switches
sites for Src kinases and for other nonreceptor tyrosinethat link a variety of extracellular cues to crucial intracel-
kinases such as Jak or ZAP-70. The nonreceptor tyro-lular signaling pathways. Recent studies have now dem-
sine kinases that bind to the cytoplasmic domains ofonstrated that in addition to their central role in receptor
these receptors by noncovalent interactions can be con-signaling and cell communication, Src kinases play an
sidered to be the catalytic domains of receptors thatimportant role in lymphokine-mediated cell survival and
lack intrinsic catalytic activities. For example, the T cellVEGF-induced angiogenesis.
receptor (TCR) forms a complex with Fyn and Lck (RuddSrc Structure and Activation
et al., 1988; Howe and Weiss, 1995). Fyn binds via itsAll Src family members are composed of several well-
unique sequence to CD3, while Lck directly associatescharacterized protein domains. The amino terminus of
with the CD4/CD8 complex. Cross-linking of TCR bySrc is myristylated, and most members of the Src family
multivalent antigens leads to activation of Fyn and Lck.
are also palmitoylated. These lipid modifications are es-
These protein tyrosine kinases phosphorylate a variety
sential for targeting of Src kinases to the inner leaflet
of downstream target proteins, including protein kinases
of cell membranes. The membrane targeting signal in and docking proteins responsible for assembling a sig-
Src is followed by a unique sequence, by SH3 and SH2 naling complex necessary for T cell activation. Similar
(Src homology) domains, by the catalytic protein tyro- mechanisms take place in B cells upon B cell receptor
sine kinase (PTK) core, and by a region in the carboxyl activation and in other cells of the immune system that
terminus that contains a conserved regulatory tyrosine are regulated by engagement of various Fc receptors
phosphorylation site (Thomas and Brugge, 1997). (Thomas and Brugge, 1997).
Detailed biochemical studies and analysis of the Src kinases are also activated by engagement of inte-
structure of Src and Hck by X-ray crystallography have grins (Schwartz et al., 1995), by a variety of G protein±
provided a consistent picture of how Src kinases are coupled receptors (Luttrell et al., 1996), and by growth
maintained in the inactive state (reviewed in Thomas factor receptor stimulation (Kypta et al., 1990). Growth
and Brugge, 1997). The protein tyrosine kinase domain factor stimulation of Src kinases is particularly intriguing
of Src is kept in an inactive state by intramolecular inter- because growth factor receptors are endowed with in-
actions mediated by the concerted actions of the SH3 trinsic protein tyrosine kinase activities. However, it was
and SH2 domains. The SH3 domain of Src binds to a convincingly demonstrated that certain tyrosine auto-
short proline type II helix region in a linker that connects phosphorylation sites on receptor tyrosine kinases (i.e.,
the protein tyrosine kinase domain to the SH2 domain. PDGF receptors) serve as docking sites for the SH2
The SH2 domain, on the other hand, is bound to pY527 domain of Src kinases (Mori et al., 1993). Indeed, ligand-
in the carboxyl terminus of Src, a residue that is phos- induced activation of PDGF receptors leads to formation
phorylated by the protein tyrosine kinase CSK. This inac- of a signaling complex, and to recruitment and activation
of Src. The binding of the SH2 domain of Src to thetive ªclosedº conformation of Src is tethered to the cell
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Figure 1. Cell Survival Induced by Lympho-
kine or Growth Factor Stimulation
Stimulation of TRANCE-R in osteoclasts
leads to complex formation with the adaptor
protein TRAF6. TRAF6 is bound by means
of a proline-containing sequence to the SH3
domain of Src thus competing with the SH3
domain for binding to the proline-containing
linker region and contributing toward the re-
lease of the protein tyrosine kinase from the
autoinhibited state. Ternary complex forma-
tion with oligomeric TRANCE-R leads to acti-
vation of Src. Activation of PI-3 kinase, one
of the targets of Src, leads to the production
of PtdIns(3,4,5) triphosphate (PIP3). This ino-
sitol-phospholipid serves a specific mem-
brane-linked ligand of the Pleckstrin homol-
ogy (PH) domains of PDK and PKB. After
being targeted to the membrane and phos-
phorylated by PDK, activated PKB phosphor-
ylates BAD, Caspase-9, and FKHL1 leading to inhibition of apoptotic death and stimulation of cell survival.
VEGF-induced stimulation of VEGFR in endothelial cells leads to recruitment of Src and stimulation of catalytic activity of Src. It is proposed
that Src is activated by binding of the SH2 domain to a tyrosine autophosphorylation site on VEGFR or to a tyrosine phosphorylation site on
a docking protein (not shown) that is phosphorylated by VEGFR. The binding of the SH2 domain releases Src from the autoinhibited state.
Activated Src may feed into a similar signaling pathway composed of PI-3K, PDK, and PKB leading to inhibition of apoptosis and stimulation
of endothelial cell survival and angiogenesis.
phosphotyrosine-containing docking site on PDGF re- such as activation of NF-kB (Rothe et al., 1994). The
TRAF proteins are composed of several subdomains.ceptor releases Src from its autoinhibited state; upon
phosphorylation of a key tyrosine residue in the activa- The N-terminal domain contains a RING and zinc fingers
and has a regulatory role. The C-terminal domain istion loop, Src becomes fully activated and ready to per-
form its cellular tasks. Activation of Src kinases in re- responsible for binding to surface receptors and to ef-
fector proteins, and it is also responsible for oligomeriza-sponse to growth factor stimulation constitutes an
essential step in the initiation of the mitogenic signal tion. Ligand-induced activation of TRANCE-R in trans-
fected cells leads to association with TRAFs 1, 2, 3, 5,generated by several receptor tyrosine kinases (Court-
neidge and Fumagalli, 1994). and 6.
Interestingly, TRANCE-induced survival of osteo-Cell Survival Dependent on Src Kinases
Studies performed in the early 1990s demonstrated that clasts isolated from Src2/2 mice was compromised rela-
tive to wild-type mice (Wong et al., 1999). Similarly,expression of v-Src can rescue certain cells from apo-
ptosis caused by cytokine deprivation or disruption of TRANCE-induced activation of Akt/PKB, a Ser/Thr ki-
nase implicated in the control of cell survival, was sig-cell binding to the extracellular matrix. It was proposed
that Src may function as a component of intracellular nificantly reduced in Src2/2 osteoclasts compared to
wild-type osteoclasts. Moreover, immunoprecipitationsignaling pathways that are activated by cytokine recep-
tors or by cell adhesion to the extracellular matrix, and experiments demonstrate that TRAF6 forms a complex
with Src and that a ternary complex composed of Src,that are essential for cell survival (McCubrey et al., 1993).
A subsequent study demonstrated that Fyn-deficient TRAF6, and TRANCE-R can be detected in ligand-stimu-
lated cells. Evidence is presented for complex formationcells are more susceptible to killing by anti-Fas antibod-
ies, providing further support for a role of Src kinases between TRAF6 and Src, but activation of Src is depen-
dent upon ligand-induced ternary complex formationin the control of cell survival (Atkinson et al., 1996).
A recent report by Wong et al. (1999) describes a new between Src, TRAF6, and TRANCE-R.
The mechanism of activation of Src probably involvesrole for Src kinases in the control of cell survival, and
provides a molecular mechanism of how Src may couple binding of a proline-containing sequence in the carboxyl
terminus of TRAF6 to the SH3 domain of Src. This wouldlymphokine receptor activation with inhibition of cell
apoptosis. In this report, the authors explore cellular contribute to the activation of Src from the autoinhibited
state and bring about the formation of ªopenº conforma-signaling pathways that play a role in the control of cell
survival by TRANCE-R, the receptor for the TNF family tion of the enzyme (Figure 1). Since TRAF6 is also bound
to the receptor protein, ligand-induced oligomerizationcytokine TRANCE (TNF-related activation induced cyto-
kine, also known as RANKL, ODF, or OPGL). TRANCE-R of TRANCE-R may facilitate trans-autophosphorylation
and stimulation of the catalytic activity of Src. Stimula-is expressed on dendridic cells and on osteoclasts;
receptor stimulation leads to cell survival and expres- tion of Src leads to activation of PI-3 kinase. This pro-
vides evidence for a role for PI-3 kinase in activationsion of T cell regulatory cytokines. TRANCE-R, like other
members of the TNF receptor family, lacks intrinsic cata- of PKB and prevention of apoptotic death (Figure 1).
Although the role of PDK [PtdIns(3,4,5)-dependent ki-lytic activities; it mediates its biological effects by re-
cruitment of adaptor proteins designated TRAFs (TNF- nase] was not analyzed, it is likely that PI-3 kinase-
induced production of PtdIns(3,4,5) triphosphate leadsreceptor associated factors), which bind to the cyto-
plasmic domain of TNFR and mediate TNF responses to membrane targeting of both PDK and PKB and that
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phosphorylation of PKB by PDK is responsible for opti- proteins. Binding of the SH2 domain of Src to tyrosine
mal activation of PKB (Figure 1). Previous studies phosphorylation site on VEGFR or on a docking protein
showed that PKB promotes cell survival by phosphory- releases Src from the autoinhibited state and enables
lation of BAD, FKHR1, and Caspase-9 (Cardone et al., the catalytic activity to be stimulated by autophosphory-
1998). The PKB-induced phosphorylation of BAD pre- lation of a key tyrosine residue in the activation-loop of
vents interaction with the proapoptotic proteins Bcl-2 the catalytic core (Figure 1). Once activated, Src could
and Bcl-xl, thus preventing apoptotic death (Zha et al., link VEGF-stimulation with the PDK/PKB signaling cas-
1996). In addition, PKB-mediated phosphorylation inhib- sette leading to stimulation of endothelial cell survival
its FKHR1 (Brunet et al., 1999), a transcriptional factor and angiogenesis. Figure 1 presents a model of how
that regulates the expression of several apoptosis- Src may function as a link between lymphokine or VEGF
inducing genes. stimulation with intracellular pathways that regulate
Wong et al. (1999) demonstrate that IL-1- and LPS- apoptotic death and cell survival.
induced activation (via Toll receptor) of PKB are also In response to certain cues, protein tyrosine kinases
dependent upon Src activation, suggesting that the sig- can switch their roles and stimulate apoptotic-death
naling pathway described above may represent a gen- rather than cell survival. Belka et al. (1999) demonstrated
eral paradigm for the control of cell survival by a variety that apoptotic death induced by Caspase-8 activation
of lymphokines (Figure 1). in response to ionizing radiation was impaired in cells
A Role for Src in Angiogenesis deficient in Lck. Moreover, ionizing radiation±induced
As mentioned above, Src kinases are activated by a Caspase-8-mediated cell death was rescued upon ex-
variety of growth factors and function downstream of pression of Lck in these cells. Another example is the
receptor tyrosine kinases (Kypta et al., 1990; Mori et al., recently described link between the protein tyrosine ki-
1993; Courtneidge and Fumagilli, 1994). Eliceiri et al. nase Abl and p73, a homolog of the p53 tumor suppres-
(1999) have now presented experiments demonstrating sor protein (Yuan et al., 1999). The SH3 domain of Abl
that VEGF and FGF stimulate Src activation in avian binds to a proline-rich region in p73, leading to formation
endothelial cells. However, although both growth factors of a complex between these two proteins. Treatment of
stimulate Src activation, only VEGF-induced angiogen- cells with DNA-damaging agents leads to activation of
esis is inhibited by treatment with a retrovirus that en- Abl, which then stimulates p73 transactivation and cell
codes for Src-251, a dominant-interfering mutant of Src. apoptosis by tyrosine phosphorylation of a key regula-
Moreover, overexpression of Src-251 in avian blood ves- tory residue.
sels induces apoptotic death, indicating that VEGF- Taken together these studies reveal the central role
induced activation of Src is essential for endothelial played by Src kinases, and the versatility by which they
cell survival and angiogenesis. Indeed, treatments of regulate matters of life, death, and other intricate intra-
animals with the Src-251 retrovirus lead to suppression cellular processes.
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